{
    "PMC": "5921804",
    "DOI": "10.1111/j.1349-7006.1998.tb00564.x",
    "PMID": "9600126",
    "PMCID": "PMC5921804",
    "title": "Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells.",
    "year": 1998,
    "source_url": "https://europepmc.org/article/PMC/PMC5921804",
    "source": "MED",
    "abstract_text": "Previously, we demonstrated that inostamycin, an inhibitor of phosphatidylinositol turnover, caused cell cycle arrest at the G1 phase, inhibiting the expression of cyclins D1 and E in normal cells. In the present study, we examined the effects of inostamycin on cell cycle progression and apoptosis in human small cell lung carcinoma Ms-1 cells. Treatment of exponentially proliferating Ms-1 cells with low concentrations of inostamycin caused cells to accumulate in the G1 phase. We found that inostamycin decreased cyclin D1, and increased cyclin-dependent kinase inhibitors such as p21WAF1 and p27KIP1 in Ms-1 cells. On the other hand, higher concentrations of inostamycin induced morphological apoptosis and DNA fragmentation in Ms-1 cells without affecting the expression of p53, Bcl-2 and Bax. Inostamycin-induced apoptosis was suppressed by an inhibitor of caspase-3, and a 17 kDa fragment of activated caspase-3 was detected following inostamycin treatment. Therefore, caspase-3(-like) would appear to be involved in inostamycin-induced apoptosis. On the other hand, an inhibitor of caspase-3(-like) proteases did not affect the inhibitory effect of inostamycin on cyclin D1 expression, suggesting that caspase-3(-like) proteases were not responsible for inostamycin-induced G1 arrest.",
    "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5921804 9600126 10.1111/j.1349-7006.1998.tb00564.x CAE315 Article Inhibition of Cyclin D1 Expression and Induction of Apoptosis by Inostamycin in Small Cell Lung Carcinoma Cells Imoto Masaya 1 Tanabe Keiko 1 Simizu Siro 1 Tashiro Etsu 1 Takada Minoru 2 Umezawa Kazuo 1 1 Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3\u201014\u20101 Hiyoshi, Kohoku\u2010ku, Yokohama 223\u20108522 2 Rinku General Medical Center, 2\u201023 Rinkuohrai\u2010kita, Izumisano\u2010shi, Osaka 598\u20108577 * To whom correspondence should be addressed. 3 1998 89 3 10.1111/cas.1998.89.issue-3 315 322 (Received October 23, 1997/Revised December 4, 1997/Accepted December 16, 1997) Previously, we demonstrated that inostamycin, an inhibitor of phosphatidylinositol turnover, caused cell cycle arrest at the G1 phase, inhibiting the expression of cyclins D1 and E in normal cells. In the present study, we examined the effects of inostamycin on cell cycle progression and apoptosis in human small cell lung carcinoma Ms\u20101 cells. Treatment of exponentially proliferating Ms\u20101 cells with low concentrations of inostamycin caused cells to accumulate in the G1 phase. We found that inostamycin decreased cyclin D1, and increased cyclin\u2010dependent kinase inhibitors such as p21 WAF1 and p27 KIP1 in Ms\u20101 cells. On the other hand, higher concentrations of inostamycin induced morphological apoptosis and DNA fragmentation in Ms\u20101 cells without affecting the expression of p53, Bcl\u20102 and Bax. Inostamycin\u2010induced apoptosis was suppressed by an inhibitor of caspase\u20103, and a 17 kDa fragment of activated caspase\u20103 was detected following inostamycin treatment. Therefore, caspase\u20103(\u2010like) would appear to be involved in inostamycin\u2010induced apoptosis. On the other hand, an inhibitor of caspase\u20103(\u2010like) proteases did not affect the inhibitory effect of inostamycin on cyclin D1 expression, suggesting that caspase\u20103(\u2010like) proteases were not responsible for inostamycin\u2010induced G1 arrest. Inostamycin Cyclin D1 Caspase\u20103 p27 KIP1 source-schema-version-number 2.0 cover-date March 1998 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 REFERENCES 1 ) Hunter , T. and Pines , J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age . Cell , 79 , 573 \u2013 582 ( 1994 ). 7954824 2 ) Lees , E. Cyclin dependent kinase regulation . Curr. Opin. Cell Biol. , 7 , 773 \u2013 780 ( 1995 ). 8608007 3 ) Kamb , A. Cell\u2010cycle regulators and cancer . Trends Genet. , 11 , 136 \u2013 140 ( 1995 ). 7732591 4 ) Sheaff , R. J. and Robert , J. M. Lessons in p16 from phylum falconium . Curr. Biol. , 5 , 28 \u2013 31 ( 1995 ). 7697342 5 ) Hengartner , M. O. and Horvitz , H. R. Programmed cell death in Caenorhabditis elegans . Curr. Opin. Genet. Dev. , 4 , 581 \u2013 586 ( 1994 ). 7950327 6 ) Yuan , J. , Shaham , S. , Ledoux , S. , Ellis , H. M. and Horvitz , H. R. The C. elegans cell death gene ced\u20103 encodes a protein similar to mammalian interleukin\u2010\u03b2\u2010converting enzyme . Cell , 75 , 641 \u2013 652 ( 1993 ). 8242740 7 ) Vaux , D. L. and Strasser , A. The molecular biology of apoptosis . Proc. Natl. Acad. Sci. USA , 93 , 2239 \u2013 2244 ( 1996 ). 8637856 8 ) Alnemri , E. S. , Livingston , D. J. , Nicholson , D. W. , Salvesen , G. , Thornberry , N. A. , Wong , W. W. and Yuan , J. Human ICE/CED\u20103 protease nomenclature . Cell , 87 , 171 ( 1996 ). 8861900 9 ) Nicholson , D. W. , Ali , A. , Thornberry , N. A. , Vaillancourt , J. P. , Ding , C. K. , Gallant , M. , Gareau , Y. , Griffin , P. R. , Labelle , M. , Lazebnik , Y. A. , Munday , N. A. , Raju , S. M. , Smulson , M. E. , Yamin , T.\u2010T. , Yu , V. L. and Miller , D. K. Identification and inhibition of the ICE/CED\u20103 protease necessary for mammalian apoptosis . Nature , 376 , 37 \u2013 43 ( 1995 ). 7596430 10 ) Hengartner , M. O. and Horvitz , H. R. C. elegans cell\u2010survival gene ced\u20109 encodes a functional homolog of the mammalian protooncogene bcl\u20102 . Cell , 76 , 665 \u2013 676 ( 1994 ). 7907274 11 ) Reed , J. C. Bcl\u20102 and regulation of programmed cell death . J. Cell Biol. , 124 , 1 \u2013 6 ( 1994 ). 8294493 12 ) Oltvai , Z. N. and Korsmeyer , S. J. Checkpoints of dueling dimers foil death wishes . Cell , 79 , 189 \u2013 192 ( 1994 ). 7954787 13 ) Boise , L. H. , Gottschalk , A. R. , Quintans , J. and Thompson , C. B. Cloning and expression of vertebrate apoptosis gene bcl\u2010X and use of gene or BCL\u2010X protein in diagnosis and therapy . Curr. Top. Microbiol. Immunol. , 200 , 107 \u2013 121 ( 1995 ). 7634826 14 ) Lee , S. , Christakos , S. and Small , M. B. Apoptosis and signal transduction: clues to a molecular mechanism . Curr. Opin. Cell Biol. , 5 , 286 \u2013 291 ( 1993 ). 8507500 15 ) Imoto , M. , Umezawa , K. , Takahashi , Y. , Naganawa , H. , Iitaka , Y. , Nakamura , H. , Koizumi , Y. , Sasaki , Y. , Hamada , M. , Sawa , T. and Takeuchi , T. Isolation and structure determination of inostamycin, a novel inhibitor of phosphatidylinositol turnover . J. Nat. Prod. , 53 , 825 \u2013 829 ( 1990 ). 16 ) Imoto , M. , Taniguchi , Y. and Umezawa , K. Inhibition of CDP\u2010DG: inositol transferase by inostamycin . J. Biochem. , 112 , 299 \u2013 302 ( 1992 ). 1328172 17 ) Imoto , M. , Morii , T. , Deguchi , A. and Umezawa , K. Involvement of phosphatidylinositol synthesis in the regulation of S phase induction . Exp. Cell Res. , 215 , 228 \u2013 233 ( 1994 ). 7957673 18 ) Deguchi , A. , Imoto , M. and Umezawa , K. Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor . J. Biochem. , 120 , 1118 \u2013 1122 ( 1996 ). 9010759 19 ) Fernandes\u2010Alnemri , T. , Armstrong , R. C. , Krebs , J. , Srinivasula , S. M. , Wang , L. , Bullrich , F. , Fritz , L. C. , Trapani , J. A. , Tomaselli , K. J. , Litwack , G. and Alnemri , E. S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD\u2010like domains . Proc. Natl. Acad. Sci. USA , 93 , 7464 \u2013 7469 ( 1996 ). 8755496 20 ) Helin , K. , Lees , J. A. , Vidal , M. , Dyson , N. , Harlow , E. and Fattaey , A. A. cDNA encoding a pRB\u2010binding protein with properties of the transcription factor E2F . Cell , 70 , 337 \u2013 350 ( 1992 ). 1638634 21 ) Krek , W. , Ewen , M. E. , Shirodkar , S. , Arany , Z. , Kaelin Jr. , W. G. and Livingston , D. M. Negative regulation of the growth\u2010promoting transcription factor E2F\u20101 by a stably bound cyclin A\u2010dependent protein kinase . Cell , 78 , 161 \u2013 172 ( 1994 ). 8033208 22 ) Baldin , V. , Lukas , J. , Marcote , M. J. , Pagano , M. and Draetta , G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1 . Genes Dev. , 7 , 812 \u2013 821 ( 1993 ). 8491378 23 ) Quelle , D. E. , Ashmun , R. A. , Shurtleff , S. A. , Kato , J. , Bar\u2010Sagi , D. , Roussel , M. F. and Sherr , C. J. Overexpression of mouse D\u2010type cyclins accelerates G1 phase in rodent fibroblasts . Genes Dev. , 7 , 1559 \u2013 1571 ( 1993 ). 8339933 24 ) Lukas , J. , Jadayel , D. , Bartkova , J. , Nacheva , E. , Dyer , M. J. , Strauss , M. and Bartek , J. BCL\u20101/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B\u2010cell neoplasms carrying the t(11;14) translocation . Oncogene , 9 , 2159 \u2013 2167 ( 1994 ). 8036001 25 ) Ohtani , K. , DeGregori , J. and Nevins , J. R. Regulation of the cyclin E gene by transcriptional factor E2F1 . Proc. Natl. Acad. Sci. USA , 92 , 12146 \u2013 12510 ( 1995 ). 8618861 26 ) Botz , J. , Zerfass\u2010Thome , K. , Spitkovsky , D. , Delius , H. , Vogt , B. , Eilers , M. , Hatzigeorgiou , A. and Jansen\u2010Durr , P. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter . Mol. Cell. Biol. , 16 , 3401 \u2013 3409 ( 1996 ). 8668155 27 ) Polyak , K. , Lee , M.\u2010H. , Erdjument\u2010Bromage , H. , Tempst , P. and Massague , J. Cloning of p27KIP1, a cyclin\u2010dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals . Cell , 78 , 59 \u2013 66 ( 1994 ). 8033212 28 ) Toyoshima , H. and Hunter , T. p27, a novel inhibitor of G1 cyclin\u2010cdk protein kinase activity, is related to p21 . Cell , 78 , 67 \u2013 74 ( 1994 ). 8033213 29 ) Reynisdottir , I. , Polyak , K. , Iavarone , A. and Massague , J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF\u2010\u03b2 . Genes Dev. , 9 , 1831 \u2013 1845 ( 1995 ). 7649471 30 ) El\u2010Deiry , W. S. , Tokino , T. , Velculescu , V. E. , Levy , D. B. , Parsons , R. , Trent , J. M. , Lin , D. , Mercer , E. , Kinzler , K. W. and Vogelstein , B. WAF1, a potential mediator of p53 tumor suppression . Cell , 75 , 817 \u2013 825 ( 1993 ). 8242752 31 ) Takahashi , T. , Nau , M. M. , Chiba , I. , Birrer , M. J. , Rosenberg , R. K. , Vinocour , M. , Levitt , M. , Pass , H. , Gazdar , A. F. and Minna , J. D. p53: a frequent target for genetic abnormalities in lung cancer . Science , 246 , 491 \u2013 494 ( 1989 ). 2554494 32 ) Sameshima , Y. , Matsuno , Y. , Hirohashi , S. , Shimosato , Y. , Mizoguchi , H. , Sugimura , T. , Terada , M. and Yokota , J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small\u2010cell lung carcinoma . Oncogene , 7 , 451 \u2013 457 ( 1992 ). 1312700 33 ) Chin , Y. E. , Kitagawa , M. , Su , W.\u2010C. S. , You , Z.\u2010H. , Iwamoto , Y. and Fu , X.\u2010Y. Cell growth arrest and induction of cyclin\u2010dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1 . Science , 272 , 719 \u2013 722 ( 1996 ). 8614832 34 ) Pagano , M. , Tam , S. W. , Theodoras , A. M. , Beer\u2010Romero , P. , Sal , G. D. , Chau , V. , Yew , P. R. , Draetta , G. F. and Rolfe , M. Role of the ubiquitin\u2010proteasome pathway in regulating abundance of the cyclin\u2010dependent kinase inhibitor p27 . Science , 269 , 682 \u2013 685 ( 1995 ). 7624798 35 ) Kuniyasu , H. , Yasui , W. , Kitahara , K. , Naka , K. , Yokozaki , H. , Akama , Y. , Hamamoto , T. , Tahara , H. and Tahara , E. Growth inhibitory effect of interferon\u2010\u03b2 is associated with the induction of cyclin\u2010dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line . Cell Growth Differ. , 8 , 47 \u2013 52 ( 1997 ). 8993833 36 ) Kwon , T. K. , Buchholz , M. A. , Chrest , F. J. and Nordin , A. A. Staurosporine\u2010induced G1 arrest is associated with the induction and accumulation of cyclin\u2010dependent kinase inhibitors . Cell Growth Differ. , 7 , 1305 \u2013 1313 ( 1996 ). 8891334 37 ) Shibata , Y. , Nishimura , S. , Okuyama , A. and Nakamura , T. p53\u2010independent induction of apoptosis by cyclin\u2010dependent kinase inhibition . Cell Growth Differ. , 7 , 887 \u2013 891 ( 1996 ). 8809406 38 ) Dou , Q. P. , An , B. and Will , P. L. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53\u2010independent G1 arrest and apoptosis . Proc. Natl. Acad. Sci. USA , 92 , 9019 \u2013 9023 ( 1995 ). 7568064 39 ) Chresta , C. M. , Masters , J. R. W. and Hickman , J. A. Hypersensitivity of human testicular tumors to etoposide\u2010induced apoptosis is associated with functional p53 and a high Bax:Bcl\u20102 ratio . Cancer Res. , 56 , 1834 \u2013 1841 ( 1996 ). 8620501 40 ) Enari , M. , Talanian , R. V. , Wong , W. W. and Nagata , S. Sequential activation of ICE\u2010like and CPP32\u2010like proteases during Fas\u2010mediated apoptosis . Nature , 380 , 723 \u2013 726 ( 1996 ). 8614469",
    "full_text_abstract": "Previously, we demonstrated that inostamycin, an inhibitor of phosphatidylinositol turnover, caused cell cycle arrest at the G1 phase, inhibiting the expression of cyclins D1 and E in normal cells. In the present study, we examined the effects of inostamycin on cell cycle progression and apoptosis in human small cell lung carcinoma Ms\u20101 cells. Treatment of exponentially proliferating Ms\u20101 cells with low concentrations of inostamycin caused cells to accumulate in the G1 phase. We found that inostamycin decreased cyclin D1, and increased cyclin\u2010dependent kinase inhibitors such as p21 WAF1 and p27 KIP1 in Ms\u20101 cells. On the other hand, higher concentrations of inostamycin induced morphological apoptosis and DNA fragmentation in Ms\u20101 cells without affecting the expression of p53, Bcl\u20102 and Bax. Inostamycin\u2010induced apoptosis was suppressed by an inhibitor of caspase\u20103, and a 17 kDa fragment of activated caspase\u20103 was detected following inostamycin treatment. Therefore, caspase\u20103(\u2010like) would appear to be involved in inostamycin\u2010induced apoptosis. On the other hand, an inhibitor of caspase\u20103(\u2010like) proteases did not affect the inhibitory effect of inostamycin on cyclin D1 expression, suggesting that caspase\u20103(\u2010like) proteases were not responsible for inostamycin\u2010induced G1 arrest."
}